Literature DB >> 23255773

Invasive ductal carcinoma of the breast: correlation between tumor grade determined by ultrasound-guided core biopsy and surgical pathology.

Jiamin Zheng1, Tahra Alsaadi, Jason Blaichman, Xuanqian Xie, Attila Omeroglu, Sarkis Meterissian, Benoît Mesurolle.   

Abstract

OBJECTIVE: The purpose of this article is to evaluate the concordance between tumor grade found on ultrasound-guided core biopsies of invasive ductal carcinomas of the breast and subsequent excision specimens.
MATERIALS AND METHODS: We retrospectively studied 300 consecutive invasive ductal carcinomas (274 women) that were biopsied under sonographic guidance, using 14-gauge core needles exclusively, and that were subsequently excised surgically. A minimum of four cores were taken per lesion. Core biopsy grades were compared with final surgical grades (reference standard). Tumor grade was assigned using the standard modified Scarff-Bloom-Richardson system. The agreement rate was expressed in percentages and in kappa statistics; the rates of overestimation and underestimation were also assessed. The correlation between tumor size (small, ≤ 0.5 cm; medium, 0.6-2.4 cm; and large, ≥ 2.5 cm) and agreement rate was also evaluated.
RESULTS: The overall agreement between core biopsy and surgical pathology grade was 69% (simple κ = 0.46; 95% CI, 0.36-0.54). Agreement by biopsy grade was 86% (55/64) for grade 3, 66% (118/180) for grade 2, and 55% (23/42) for grade 1. Core biopsy underestimated 24% (70/286) and overestimated 7% (20/286) of the lesions. When discordant, core biopsy differed from excision by no more than one grade. Large tumors were more likely to show underestimation rather than overestimation when discordant (rate of underestimation, 92% for large, 81% for medium, and 33% for small tumors; p < 0.0031).
CONCLUSION: Ultrasound-guided core biopsy accurately predicts high-grade breast tumors but is moderately accurate for lower-grade lesions. Large tumor size negatively impacts the accuracy of tumor grade found on biopsy and is associated with underestimation.

Entities:  

Mesh:

Year:  2013        PMID: 23255773     DOI: 10.2214/AJR.11.7461

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  3 in total

1.  Development and verification of a personalized immune prognostic feature in breast cancer.

Authors:  HongLei Wang; Li Wu; HongTao Wang
Journal:  Exp Biol Med (Maywood)       Date:  2020-06-29

2.  Biomarker discovery to improve prediction of breast cancer survival: using gene expression profiling, meta-analysis, and tissue validation.

Authors:  Liwei Meng; Yingchun Xu; Chaoyang Xu; Wei Zhang
Journal:  Onco Targets Ther       Date:  2016-10-11       Impact factor: 4.147

Review 3.  Accuracy and Utility of Preoperative Ultrasound-Guided Axillary Lymph Node Biopsy for Invasive Breast Cancer: A Systematic Review and Meta-Analysis.

Authors:  Yihong Huang; Shuo Zheng; Yu Lin
Journal:  Comput Intell Neurosci       Date:  2022-09-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.